Hao Tian International Construction, Aceso Life Science Shareholders to Vote on Former's Share Placement

MT Newswires Live02-26

Shareholders of Hao Tian International Construction Investment Group (HKG:1341) and its controlling shareholder Aceso Life Science (HKG:0474) will meet March 18 to vote on a proposed share placement by the former, a Tuesday filing with the Hong Kong bourse said.

Hao Tian International Construction, in October, had agreed to place 1,524,224,000 shares to at least six placees to raise around HK$600 million.

Assuming full completion, Aceso Life Science's stake in Hao Tian International Construction will be diluted from roughly 29.05% to 24.2%.

The dilution will constitute a deemed disposal since Hao Tian International Construction Investment will no longer be considered a unit of Aceso Life Science and the financial results of the former will no longer be consolidated in the financial statements of the latter.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2514033530?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-26 14:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514033530","market":"sh","top_or_hot":-1,"title":"Hao Tian International Construction, Aceso Life Science Shareholders to Vote on Former's Share Placement","media":"MT Newswires Live","content":"<html><body><p> Shareholders of Hao Tian International Construction Investment Group (HKG:1341) and its controlling shareholder Aceso Life Science (HKG:0474) will meet March 18 to vote on a proposed share placement by the former, a Tuesday filing with the Hong Kong bourse said.</p><p>Hao Tian International Construction, in October, had agreed to place 1,524,224,000 shares to at least six placees to raise around HK$600 million.</p><p>Assuming full completion, Aceso Life Science's stake in Hao Tian International Construction will be diluted from roughly 29.05% to 24.2%.</p><p>The dilution will constitute a deemed disposal since Hao Tian International Construction Investment will no longer be considered a unit of Aceso Life Science and the financial results of the former will no longer be consolidated in the financial statements of the latter.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hao Tian International Construction, Aceso Life Science Shareholders to Vote on Former's Share Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHao Tian International Construction, Aceso Life Science Shareholders to Vote on Former's Share Placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-26 14:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Shareholders of Hao Tian International Construction Investment Group (HKG:1341) and its controlling shareholder Aceso Life Science (HKG:0474) will meet March 18 to vote on a proposed share placement by the former, a Tuesday filing with the Hong Kong bourse said.</p><p>Hao Tian International Construction, in October, had agreed to place 1,524,224,000 shares to at least six placees to raise around HK$600 million.</p><p>Assuming full completion, Aceso Life Science's stake in Hao Tian International Construction will be diluted from roughly 29.05% to 24.2%.</p><p>The dilution will constitute a deemed disposal since Hao Tian International Construction Investment will no longer be considered a unit of Aceso Life Science and the financial results of the former will no longer be consolidated in the financial statements of the latter.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01341","symbol_name":"昊天国际建投","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2514033530","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514033530","pubTimestamp":1740550426,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shareholders of Hao Tian International Construction Investment Group  and its controlling shareholder Aceso Life Science  will meet March 18 to vote on a proposed share placement by the former, a Tuesday filing with the Hong Kong bourse said.Hao Tian International Construction, in October, had agreed to place 1,524,224,000 shares to at least six placees to raise around HK$600 million.Assuming full completion, Aceso Life Science's stake in Hao Tian International Construction will be diluted from roughly 29.05% to 24.2%.The dilution will constitute a deemed disposal since Hao Tian International Construction Investment will no longer be considered a unit of Aceso Life Science and the financial results of the former will no longer be consolidated in the financial statements of the latter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01341":"昊天国际建投","BK1188":"消费信贷","00474":"信铭生命科技"},"translate_title":"昊天国际建设、Aceso Life Science股东将就前者的股份配售进行投票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00474":0.9,"01341":0.9},"content_text":"Shareholders of Hao Tian International Construction Investment Group (HKG:1341) and its controlling shareholder Aceso Life Science (HKG:0474) will meet March 18 to vote on a proposed share placement by the former, a Tuesday filing with the Hong Kong bourse said.Hao Tian International Construction, in October, had agreed to place 1,524,224,000 shares to at least six placees to raise around HK$600 million.Assuming full completion, Aceso Life Science's stake in Hao Tian International Construction will be diluted from roughly 29.05% to 24.2%.The dilution will constitute a deemed disposal since Hao Tian International Construction Investment will no longer be considered a unit of Aceso Life Science and the financial results of the former will no longer be consolidated in the financial statements of the latter.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514033530","isCrawlerRequest":true}